Ketek Oral Tablet 400Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ketek: Oral tablet (400mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_7277.JPG
Ketek 400mg Tab
Sanofi-Aventis US LLC
Pill Identification: H3647  |  400
Drug Image file DrugItem_7278.JPG
Ketek Pak 400mg Tab
Sanofi-Aventis US LLC
Pill Identification: H 3647  |  400

What is this Medicine?

TELITHROMYCIN (tel ith roe MYE sin) is a ketolide antibiotic. It is used to treat certain kinds of bacterial infections.This medicine will not work for colds, flu, or other viral infections.

In-Depth Information

Ketek 400mg Tablet

NDC: 000882225
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Community-acquired Pneumonia

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Ketek 400mg Tablet
Drug Image file DrugItem_7277.JPG
Sanofi-Aventis US LLC
Pill Identification: H3647  |  400
Shape: oval
Color: orange

Reported Side Effects for Ketek 400mg Tablet

Balance Problems Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Yellow Skin Incidence:
<0.7%*
Severity: MODERATE
Onset: DELAYED
Muscle Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Blurred Vision Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Double Vision Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
<0.2%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
<0.2%*
Severity: MILD
Onset: RAPID
Inflamed Tongue Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Weakness Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
<0.2%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Anosmia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Decreased Appetite Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<0.2%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
<0.2%*
Severity: SEVERE
Onset: RAPID
Yeast Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Eczema Vaccinatum Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
<0.2%*
Severity: MILD
Onset: RAPID
Torsade De Pointes Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
High Platelet Count Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<0.2%*
Severity: MILD
Onset: RAPID
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
<0.2%*
Severity: MODERATE
Onset: RAPID
Excessive Sweating Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
<0.2%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
0.7%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
2.4%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.8%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Ketek 400mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Ketek 400mg Tablet(Telithromycin)
Marijuana and Telithromycin(Telithromycin)
Telithromycin can theoretically decrease the elimination of Marijuana, Medical from the body. Side effects from Marijuana, Medical may worsen if you take Telithromycin. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ketek

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5